Michael Grunwald, MD, FACP

No bio available.

Financial relationships

  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Ajax
    Topic:
    research funding to institution
    Date added:
    07/16/2024
    Date updated:
    04/21/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Incyte
    Topic:
    research funding to institution
    Date added:
    07/16/2024
    Date updated:
    04/21/2025
  • Attribution:
    Other
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Janssen
    Topic:
    research funding to institution
    Date added:
    07/16/2024
    Date updated:
    04/21/2025
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    Medtronic
    Date added:
    07/16/2024
    Date updated:
    04/21/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Aptitude Health
    Date added:
    07/16/2024
    Date updated:
    04/21/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    OncLive
    Date added:
    07/16/2024
    Date updated:
    04/21/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Disc Medicine
    Date added:
    04/21/2025
    Date updated:
    04/21/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Janssen
    Date added:
    04/21/2025
    Date updated:
    04/21/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Takeda
    Date added:
    04/21/2025
    Date updated:
    04/21/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Cogent Biosciences
    Date added:
    04/21/2025
    Date updated:
    04/21/2025

Pages

Return to North Carolina Hematologic Malignancies Symposium